(Sept. 15, 2014) Thomson Reuters Research Analytics has rated EU-AIMS – the autism research program of the European Innovative Medicines Initiative (IMI) – as the initiative’s best-performing area. The rating is based on the number and quality of scientific papers coming out of the program.
Today, the U.S. Department of Health & Human Services announced the appointment of Autism Speaks Chief Science Officer Rob Ring as a new public member of the Interagency Autism Coordinating Committee (IACC). The committee advises the government on federally funded autism research and related activities. It also provides a forum for public input on these issues.
Autism Speaks is pleased to announce its 2014 class of Meixner Postdoctoral Fellows in Translational Research. The fellowship program invests in rising talent within the autism research community and is supported by a generous gift by the estate of the late Charles Meixner.
Research funded by Autism Speaks has provided the most comprehensive and current estimate of autism’s costs to individuals, families and society:
Researchers funded by Autism Speaks have helped devise a “genetic formula” that promises to improve the accuracy of early screening for autism and speed the identification of biological targets for future treatments.